A detailed history of Twelve Points Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Twelve Points Wealth Management LLC holds 6,135 shares of ABBV stock, worth $1.08 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
6,135
Previous 5,627 9.03%
Holding current value
$1.08 Million
Previous $965,000 25.49%
% of portfolio
0.39%
Previous 0.35%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $83,230 - $101,259
508 Added 9.03%
6,135 $1.21 Million
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $57,581 - $67,242
372 Added 7.08%
5,627 $965,000
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $53,699 - $61,185
336 Added 6.83%
5,255 $956,000
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $42,380 - $47,730
308 Added 6.68%
4,919 $762,000
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $32,595 - $37,734
244 Added 5.59%
4,611 $687,000
Q2 2023

Jul 13, 2023

BUY
$132.51 - $164.9 $102,827 - $127,962
776 Added 21.61%
4,367 $588,000
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $44,395 - $51,127
307 Added 9.35%
3,591 $572,000
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $2,074 - $2,488
-15 Reduced 0.45%
3,284 $0
Q3 2022

Oct 20, 2022

BUY
$134.21 - $153.93 $58,515 - $67,113
436 Added 15.23%
3,299 $443,000
Q2 2022

Jul 18, 2022

BUY
$137.62 - $174.96 $78,993 - $100,427
574 Added 25.08%
2,863 $439,000
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $86,842 - $107,747
658 Added 40.34%
2,289 $371,000
Q4 2021

Mar 18, 2022

BUY
$107.43 - $135.93 $175,218 - $221,701
1,631 New
1,631 $221,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Twelve Points Wealth Management LLC Portfolio

Follow Twelve Points Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twelve Points Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twelve Points Wealth Management LLC with notifications on news.